- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Neuroblastoma (Metaiodobenzylguanidine
Total 588 results
-
Eli Lilly and CompanyChildren's Oncology GroupCompletedOsteosarcoma | Ependymoma | Medulloblastoma | Rhabdomyosarcoma | Sarcoma, Ewing's | Neuroblastoma (Measurable Disease) | Neuroblastoma (Metaiodobenzylguanidine | Positive Evaluable) | Non-brainstem High-grade GliomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingStage 4S Neuroblastoma | Ganglioneuroblastoma | Stage 2A Neuroblastoma | Stage 2B Neuroblastoma | Stage 3 Neuroblastoma | Stage 4 Neuroblastoma | Stage 1 Neuroblastoma | Stage 2 NeuroblastomaUnited States, Canada, Australia, New Zealand
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Neuroblastoma | Disseminated Neuroblastoma | Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S NeuroblastomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingLocalized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Ganglioneuroblastoma | Stage 4 NeuroblastomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingRecurrent Neuroblastoma | Stage 4S Neuroblastoma | Stage 2A Neuroblastoma | Stage 2B Neuroblastoma | Stage 3 Neuroblastoma | Stage 4 NeuroblastomaUnited States, Canada, Australia, New Zealand
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Neuroblastoma | Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Stage 4 NeuroblastomaUnited States, Canada, Australia, New Zealand, Puerto Rico
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Neuroblastoma | Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Stage 4 NeuroblastomaUnited States, Canada, Australia, New Zealand, Puerto Rico, Switzerland
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingLocalized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Ganglioneuroblastoma | Stage 4 NeuroblastomaUnited States, Puerto Rico, Canada, Australia, New Zealand, Netherlands, Saudi Arabia, Switzerland
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Neuroblastoma | Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4 NeuroblastomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLocalized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S NeuroblastomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Neuroblastoma | Disseminated Neuroblastoma | Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Stage 4S NeuroblastomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Neuroblastoma | Disseminated Neuroblastoma | Localized Unresectable Neuroblastoma | Regional NeuroblastomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLocalized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Stage 4 NeuroblastomaUnited States, Canada, Australia
-
National Cancer Institute (NCI)CompletedRecurrent Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Stage 4 NeuroblastomaUnited States, Canada
-
National Cancer Institute (NCI)CompletedPain | Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Stage 4 Neuroblastoma | Neurotoxicity SyndromeUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingRecurrent Neuroblastoma | Refractory Neuroblastoma | High Risk NeuroblastomaUnited States, Canada, Puerto Rico, Australia, New Zealand
-
Stephan Grupp MD PhDChildren's Hospital of Philadelphia; University of Pennsylvania; Tmunity TherapeuticsRecruitingRefractory Neuroblastoma | High-risk Neuroblastoma | Relapsed NeuroblastomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Neuroblastoma | Disseminated Neuroblastoma | Regional NeuroblastomaUnited States
-
Emory UniversityRecruitingNeuroblastoma | Refractory Neuroblastoma | Relapsed NeuroblastomaUnited States
-
Clarity Pharmaceuticals LtdRecruitingNeuroblastoma | Refractory Neuroblastoma | Relapsed NeuroblastomaUnited States
-
University of VirginiaNational Cancer Institute (NCI)UnknownRecurrent Neuroblastoma | Disseminated NeuroblastomaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingNeuroblastoma | High-risk Neuroblastoma | Metastatic NeuroblastomaUnited States
-
Nationwide Children's HospitalRecruitingRefractory Neuroblastoma | Relapsed NeuroblastomaUnited States
-
Giselle ShollerVan Andel Research InstituteCompletedRefractory Neuroblastoma | Relapsed NeuroblastomaUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Neuroblastoma | Disseminated NeuroblastomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingNeuroblastoma | Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | GanglioneuroblastomaUnited States, Canada, Saudi Arabia, Puerto Rico, Australia, New Zealand
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Neuroblastoma | Disseminated NeuroblastomaUnited States, Canada
-
M.D. Anderson Cancer CenterElevar TherapeuticsNot yet recruitingMetastatic Olfactory Neuroblastoma | Recurrent Olfactory NeuroblastomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Neuroblastoma | Refractory NeuroblastomaUnited States, Canada
-
National Cancer Institute (NCI)SuspendedRecurrent Neuroblastoma | Recurrent Osteosarcoma | Refractory Neuroblastoma | High Risk Neuroblastoma | Resectable OsteosarcomaUnited States, Canada
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); Solving Kids' Cancer; Wade's Army; Midwest Athletes... and other collaboratorsWithdrawnOsteosarcoma | Neuroblastoma | Recurrent Neuroblastoma | Relapsed NeuroblastomaUnited States
-
Cancer Research UKCompleted
-
Yizhuo ZhangRecruitingNeuroblastoma in ChildrenChina
-
Samsung Medical CenterMinistry of Health, Republic of KoreaUnknownHigh Risk Neuroblastoma
-
Belarusian Research Center for Pediatric Oncology...Recruiting
-
Memorial Sloan Kettering Cancer CenterY-mAbs TherapeuticsActive, not recruiting
-
St. Jude Children's Research HospitalMayo ClinicTerminatedAbdominal NeuroblastomaUnited States
-
Giselle ShollerY-mAbsRecruitingHigh-risk NeuroblastomaUnited States, Canada
-
Baylor College of MedicineNew Approaches to Neuroblastoma Therapy ConsortiumCompletedNEUROBLASTOMAUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisRecruitingHigh-Risk NeuroblastomaFrance, Spain, United Kingdom, Norway, Sweden, Finland, Australia, Czechia, Italy, Netherlands, Slovenia, Switzerland, Belgium, Denmark, Greece, Lithuania
-
BeiGeneCompleted
-
Memorial Sloan Kettering Cancer CenterNo longer available
-
National Cancer Institute (NCI)CompletedHigh Risk NeuroblastomaUnited States
-
United TherapeuticsTerminatedPrimary Refractory NeuroblastomaUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisNational Cancer Institute, FranceTerminatedVery High Risk NeuroblastomaItaly, Austria, France, Netherlands, Spain
-
Sinobioway Cell Therapy Co., Ltd.Children's Hospital of Fudan University; Nanjing Children's HospitalUnknownRelapsed or Refractory NeuroblastomaChina
-
Giselle ShollerBeat NB Cancer Foundation; Because of Ezra; K C Pharmaceuticals Inc.Active, not recruitingNeuroblastoma RecurrentUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent NeuroblastomaUnited States, Canada
-
National University Hospital, SingaporeUnknownNeuroblastoma RecurrentSingapore
-
National Cancer Institute (NCI)Active, not recruitingGanglioneuroblastoma | High Risk NeuroblastomaUnited States, New Zealand, Australia